Eddie Lynch
About Eddie Lynch
Eddie Lynch serves as the Senior Director of National Sales at TransMedics, Inc., where he has worked since 2021. He specializes in cross-functional leadership and has significantly contributed to the company's growth in U.S. sales.
Work at TransMedics
Eddie Lynch serves as the Senior Director of National Sales at TransMedics, Inc. since 2021. In this role, he leads a commercial team dedicated to increasing the volume of viable transplantable organs through normothermic organ perfusion technology. His responsibilities include overseeing sales strategies and fostering partnerships between clinical teams and industry stakeholders to enhance patient outcomes.
Previous Experience at TransMedics
Prior to his current position, Eddie Lynch worked as the East Regional Manager at TransMedics, Inc. from 2018 to 2022. In this capacity, he was responsible for managing sales operations in the Greater Boston area. His experience in this role contributed to his understanding of the market and strengthened his ability to connect clinicians with innovative medical solutions.
Education and Expertise
Eddie Lynch studied Biology at Boston College, where he earned a Bachelor of Science degree from 1981 to 1985. He completed his secondary education at Woonsocket Senior High School from 1978 to 1981. His academic background in biology supports his expertise in the medical sales field, particularly in emerging technologies related to organ transplantation.
Achievements in Sales Growth
Eddie Lynch played a significant role in the growth of TransMedics, Inc., contributing to an increase in U.S. sales from $7 million to $450 million. This growth culminated in a $3.3 billion acquisition, highlighting his impact on the company's success. His focus on cross-functional leadership within sales and clinical organizations has been instrumental in navigating emerging markets.
Specialization in Emerging Technologies
Eddie Lynch specializes in cross-functional leadership within sales and clinical organizations, particularly in emerging markets. He has been involved in the introduction and development of new heart failure technologies, showcasing his commitment to advancing medical solutions that improve patient care.